Find out about the MHRA Submissions Portal by talking to our team.
Articles filtered by tag
Latest news from EMA regarding nitrosamines
Our latest regulatory update focuses on the responsibilities of the Marketing Authorisation Holder.
Our latest Industry Update for Q2 covers the latest regulatory information around COVID-19 and much more.
The deadline for Nitrosamine Risk Evaluation is looming. Are you ready?
With just one month to go, have you completed your risk evaluations? Make sure you are ready!
Two Months to Go – Human medicinal product licences to be reviewed for the presence of Nitrosamine Impurities
Nitrosamines, TOPRA, & Drug Development News are the focus for our Q4 Industry Insights
The final report on the SME Day at EMA focuses on the Committee for Advanced Therapies, new Medical Devices Regulation and a Brexit update.
Part Two of the report from the SME Day at the EMA focuses on Marketing Authorisations and more.
Larissa Gould reports from the EMA in Canary Wharf on the latest developments.